ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Environmental factors"

  • Abstract Number: 0680 • ACR Convergence 2022

    Association of Environmental Risk Factors with Antiphospholipid Antibodies and Thrombosis in 1199 International Patients Referred for Suspected Antiphospholipid Syndrome

    Medha Barbhaiya1, Deanna Jannat-Khah, DrPH, MSPH1, Jonah Levine1, Karen Costenbader2 and Doruk Erkan1, 1Hospital for Special Surgery, New York, NY, 2Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Whether environmental risk factors induce antiphospholipid antibody (aPL) positivity and increase the risk of arterial thrombosis (AT) and venous thromboembolism (VTE) in aPL-positive patients…
  • Abstract Number: 0802 • ACR Convergence 2022

    Is There Any Relationship Between Helicobacter Pylori and Rheumatoid Arthritis?

    Hui Wu, Hanmei Yuan and Chao Wu, The Eighth Affiliated Hospital of Sun Yat-sen University, Shen zhen, China

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint damage. Recently, several studies suggest that gut microbiota could promote RA progression. Helicobacter…
  • Abstract Number: 1138 • ACR Convergence 2022

    Whole-Blood DNA Methylation Analysis Reveals Respiratory Environmental Traits Involved in COVID-19 Severity Following SARS-CoV-2 Infection and Common Molecular Signatures with Autoimmune Diseases

    Guillermo Barturen1, Elena Carnero-Montoro1, Manuel Martinez-Bueno1, Silvia Rojo-Rello2, Beatriz Sobrino3, Clara Alcántara-Domínguez4, David Bernardo5 and Marta Alarcon-Riquelme1, 1Center for Genomics and Oncological Research (GENYO), Granada, Spain, 2Hospital Clínico Universitario, Valladolid, Spain, 3Hospital Regional de Málaga, Málaga, Spain, 4Lorgen G.P., SL, Granada, Spain, 5Universidad de Valladolid-CSIC, Valladolid, Spain

    Background/Purpose: SARS-CoV-2 causes a severe inflammatory syndrome (COVID-19) leading, in many cases, to bilateral pneumonia, severe dyspnea and in ~5% of these, death. DNA methylation…
  • Abstract Number: 0988 • ACR Convergence 2021

    Risk Prediction Models for Incident Systemic Lupus Erythematosus Using Lifestyle/Environmental Risk Factors and a Genetic Risk Score

    Jing Cui1, Susan Malspeis1, May Choi2, Bing Lu3, Jeffrey Sparks4, Kazuki Yoshida4 and Karen Costenbader5, 1Brigham Women's Hospital, Boston, MA, 2Brigham and Women's Hospital | University of Calgary, Calgary, AB, Canada, 3Brigham and Women's Hospital and Harvard Medical School, Newton, MA, 4Brigham and Women's Hospital, Boston, MA, 5Brigham and Women's Hospital, Belmont, MA

    Background/Purpose: The identification of lifestyle/environmental and genetic factors, influencing SLE risk introduces the potential to develop risk prediction models. We examined SLE risk prediction incorporating…
  • Abstract Number: 1021 • ACR Convergence 2021

    Organic Dust Exposure Induces Post-translational Protein Modifications and a HLA-DR4-dependent Pro-inflammatory Lung Phenotype in a Murine Model of Interstitial Lung Disease

    Jill Poole1, Ted Mikuls1, Amy Nelson1, Rohit Gaurav1, Michael Duryee1, Geoffrey Thiele1, Bryant England1 and Dana Ascherman2, 1University of Nebraska Medical Center, Omaha, NE, 2University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: Environmental and occupational exposures have been epidemiologically linked to the development of rheumatoid arthritis-associated interstitial lung disease (RA-ILD). Previous investigation and modeling have also…
  • Abstract Number: 1023 • ACR Convergence 2021

    Racial and Ethnic Distribution of Rheumatic Diseases in Health Systems of the National Patient-Centered Clinical Research Network

    William Nowell1, Edward L. Barnes2, Nupur Parikh1, Shilpa Venkatachalam1, Michael Kappelman2, Jeffrey Curtis3, Peter Merkel4, Dianne Shaw5, Kalen Young5 and Michael George4, 1Global Healthy Living Foundation, Upper Nyack, NY, 2University of North Carolina at Chapel Hill, Chapel Hill, NC, 3Division of Clinical Immunology and Rheumatology, Department of Medicine, Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, 4University of Pennsylvania, Philadelphia, PA, 5Vasculitis Foundation, Kansas City, MO

    Background/Purpose: Ensuring adequate representation of racial/ethnic minorities in research necessitates understanding the prevalence of rheumatic and musculoskeletal diseases in these populations. We sought to evaluate…
  • Abstract Number: 1047 • ACR Convergence 2021

    Exposure to Industrial Pollutants and Mortality Due to Inmune-mediated Inflammatory Systemic Diseases (IMD) in Spain

    ana Perez1, Arturo Rodriguez Pérez2, Pablo Fernandez-Navarro3, Fernando Albarran4, Cristina Bohorquez4, Atusa Movasat4, Lucia Ruiz4, Paula Pretel4, elena Rabadan4, Valentina Emperiale4, Adrian abbasi5, julio suarez5, Lorena Montano4, emilio rico5, alfredo prieto2, melchor Alvarez de Mon5 and beatriz perez3, 1Hospital Universitario Príncipe de Asturias. Rheumatology. Medicine Faculty. Alcala University Department., Madrid, Spain, 2Faculty of Medicine. Alcala University, Alcala de Henares, Spain, 3Department of Epidemiology of Chronic Diseases.National Center of Epidemiology/CIBERESP. Instituto de Salud Carlos III, Madrid, Spain, 4Hospital Universitario Príncipe de Asturias, Rheumatology Department, Alcala de Henares, 5Hospital Universitario Príncipe de Asturias, Madrid, Spain

    Background/Purpose: The etiology of many IMD is largely unknown; however, available data suggest that environmental contaminants could play a role in their origin. Industrial facilities…
  • Abstract Number: 1772 • ACR Convergence 2021

    Autologous EBV-specific Cytotoxic T Cells in Systemic Lupus Erythematosus: An Innovative Phase I/IIa Clinical Trial

    Antoine Enfrein1, Beatrice Clemenceau2, Soraya Saiagh3, Céline Bressollette4, Zahir Amoura5, Henri Vie2 and Mohamed Hamidou1, 1Médecine interne, CHU de Nantes, Nantes, France, 2Inserm U1232, Université de Nantes, Nantes, France, 3Unité de Thérapie Cellulaire et Génique, CHU de Nantes, Nantes, France, 4Laboratoire de Virologie, CHU de Nantes, Nantes, France, 5Médecine interne, Hôpital Pitié Salpêtrière, AP-HP, Paris, France

    Background/Purpose: Epstein-Barr Virus (EBV) has been suggested as a potential environmental factor in systemic lupus erythematosus (SLE) onset and disease activity. Here, we report the…
  • Abstract Number: 0739 • ACR Convergence 2021

    Contextual Factors Should Complete the Assessment of Functioning in Patients with Axial Spondyloarthritis (axSpA)

    Uta Kiltz1, Eerik Ahomaa2, Björn Buehring1, Xenofon Baraliakos1, David Kiefer1, Jaclyn-Dalisay Leicht1 and Jürgen Braun1, 1Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Herne, Germany, 2St. Franziskus-Hospital, Department of Orthopedic Surgery, Cologne, Germany

    Background/Purpose: Functioning of axSpA patients (pat.) is influenced by many factors, but how contextual factors influence functioning isn’t well studied. According to the International Classification…
  • Abstract Number: 0091 • ACR Convergence 2020

    Helicobacter Pylori Infection, Autoimmune Disease and Paraproteinemia Influence the Presentation of a Cohort of 150 Pernicious Anemia Patients Diagnosed in a Rheumatology Clinic

    Michael Lovy1, Norma Daniela Aguirre Vega1 and Crystal Escobar1, 1Desert Oasis Healthcare, Palm Springs, CA

    Background/Purpose: The most familiar presentation of pernicious anemia is an elderly Northern European woman with hematologic and neurologic manifestations.  More recently the influence of Helicobacter…
  • Abstract Number: 0495 • ACR Convergence 2020

    Epstein Barr Virus (EBV), an Etiologic Factor for Systemic Lupus Erythematosus (SLE), Interacts with SLE Risk Loci Through EBV-encoded Transcription Co-factors (co-TFs)

    Viktoryia Laurynenka1, Xiaoting Chen1, Sreeja Parameswaran1, Shruti Eswar2, Kenneth Kaufman3, Bahram Namjou4, Matthew Weirauch5, Leah Kottyan4 and John Harley6, 1Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2Cincinnati Children’s Hospital Medical Center, Cincinnati, 3Cincinnati Children’s Hospital Medical Center;US Department of Veterans Affairs Medical Center, Cincinnati, OH, 4Cincinnati Children’s Hospital Medical Center/Univ of Cincinnati, Cincinnati, OH, 5Cincinnati Children’s Hospital Medical Center/Univ of Cincinnati, 535 Terrace Ave, 6Cincinnati Children's Hospital Medical Center/Univ of Cincinnati College of Medicine, Cincinnati, OH

    Background/Purpose: SLE affects millions worldwide. The etiology of this complex autoimmune disease is the consequence of both strong genetic and environmental components. Genome-wide association studies…
  • Abstract Number: 0757 • ACR Convergence 2020

    Sunlight Exposure, Sun-protective Behaviour, and Anti-citrullinated Protein Antibody Positivity: A General Population-based Study in Quebec, Canada

    Naizhuo Zhao1, Audrey Smargiassi2, Ines Colmegna3, Marie Hudson4, Marvin Fritzler5 and Sasha Bernatsky6, 1McGill University, Montreal, Canada, 2l’Université de Montréal, Montreal, Canada, 3The Research Institute of the McGill University Health Centre, Montreal, Canada, 4Division of Rheumatology, Jewish General Hospital, Montréal, QC, Canada, 5Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 6The Research Institute of the McGill University Health Centre, Montreal, ON, Canada

    Background/Purpose: Sunlight exposure has been associated with lower rheumatoid arthritis (RA) risk, but to our knowledge, no one has ever studied sunlight exposure and anti-citrullinated…
  • Abstract Number: 0779 • ACR Convergence 2020

    Antibody Responses to Epstein-Barr Virus Are Altered in the Pre-Clinical Period of Rheumatoid Arthritis

    Sabrina Fechtner1, Heather Berens2, Elizabeth Bemis3, M Kristen Demoruelle2, Carla J. Guthridge4, John Harley5, Judith James6, Jess Edison7, Kevin D. Deane8, Jill Norris9 and V. Michael Holers2, 1University of Colorado, Aurora, CO, 2University of Colorado, Denver, CO, 3Colorado School of Public Health Anschutz Medical Campus, Aurora, CO, 4Oklahoma Medical Research Foundation, Oklahoma City, OK, 5Cincinnati Children's Hospital Medical Center/Univ of Cincinnati College of Medicine, Cincinnati, OH, 6Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation;Department of Pathology, University of Oklahoma Health Sciences Center;Department of Medicine, University of Oklahoma Health Sciences Center, Edmond, OK, 7Walter Reed National Military Medical Center, Bethesda, 82 Division of Rheumatology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA, Colorado, 9Colorado School of Public Health, Aurora, CO

    Background/Purpose: Viral infections, including infection with Epstein-Barr virus (EBV), have been suggested as environmental risk factors for rheumatoid arthritis (RA). EBV infections are known to…
  • Abstract Number: 0965 • ACR Convergence 2020

    Repetitive Inhalant Lipopolysaccharide Exposure in the Setting of Arthritis Induction Potentiates Pro-Fibrotic Inflammatory Lung Disease in Mice

    Madison Wolfe1, Ted Mikuls1, Geoffrey Thiele1, Amy Nelson1, Michael Duryee1, Rohit Gaurav1, Bryant England1, Debra Romberger1 and Jill Poole1, 1University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Rheumatoid arthritis (RA) is associated with several lung diseases. Various airborne exposures have been implicated as RA disease risk factors including cigarette smoke and…
  • Abstract Number: 1008 • ACR Convergence 2020

    Assessing Improved Risk Prediction of Seropositive Rheumatoid Arthritis by Environmental, Genetic, and Preclinical Plasma Metabolite Factors

    Karen Costenbader1, Jeffrey Sparks2, Elizabeth Karlson3, Kazuki Yoshida4, Jing Cui5, Susan Malspeis6 and Lilia Bouzit7, 1Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 2Division of Rheumatology, Inflammation, and Immunity; Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, 3Brigham and Women's Hospital, Boston, MA, 4Brigham & Women's Hospital and Harvard Medical School, Boston, MA, 5Brigham Women's Hospital, Boston, MA, 6Brigham and Women's Hospital, Boston, 7Harvard Chan School of Public Health, Boston, MA

    Background/Purpose: Recent research has advanced the understanding of associations between environmental, genetic, and metabolic factors and rheumatoid arthritis (RA), introducing potential to improve risk prediction.…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 8
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology